Suppr超能文献

胆囊和胆道癌的预后因素

Prognostic factors in gallbladder and biliary tract cancer.

作者信息

Gómez-Roel Xóchitl, Arrieta Oscar, León-Rodríguez Eucario

机构信息

Department of Hematology and Oncology, Institute Nacional de Ciencias Médicas y Nutrición, Mexico City.

出版信息

Med Oncol. 2007;24(1):77-83. doi: 10.1007/BF02685906.

Abstract

BACKGROUND

Cancers of the gallbladder and bile ducts are uncommon neoplasms with poor survival. Prognostic factors are not well defined because of the scant number of patients reported through series of cases.

METHODS

We reviewed the medical records of patients with cancer of the bile ducts and gallbladder between the years 1979 and 1998, and analyzed their characteristics according to location (gallbladder, extrahepatic biliary tract, intrahepatic biliary tract, and Klatskin tumors).

RESULTS

One hundred and sixty-eight patients were included; the mean follow-up time was 238 +/- 54 d. The tumor found at more advanced stages was the biliary tract tumor. Overall survival time was 254 +/- 40 d. Location did not influence survival. The factors significantly associated to increased survival were age at diagnosis less than 50 yr (p = 0.0065), surgical treatment (p < 0.001), adjuvant chemotherapy and radiotherapy (p < 0.001 and p = 0.0072, respectively), surgical treatment with curative purpose (p < 0.001), stage of the disease (p < 0.0001), absence of jaundice (p = 0.0425), and absence of weight loss (p = 0.0446). In the multivariate analysis the significant variables were age, surgical treatment, adjuvant chemotherapy, surgery with curative purpose, stage of the disease, and absence of jaundice.

CONCLUSIONS

Cancers of the bile ducts are neoplasms known to have a poor prognosis. Chemotherapy was an independent survival factor despite the context, there is need of future studies to define its role on this disease.

摘要

背景

胆囊癌和胆管癌是罕见肿瘤,生存率低。由于通过系列病例报告的患者数量稀少,预后因素尚未明确界定。

方法

我们回顾了1979年至1998年间胆管癌和胆囊癌患者的病历,并根据肿瘤位置(胆囊、肝外胆管、肝内胆管和肝门部胆管癌)分析了其特征。

结果

共纳入168例患者;平均随访时间为238±54天。发现处于更晚期阶段的肿瘤是胆管肿瘤。总生存时间为254±40天。肿瘤位置不影响生存。与生存率增加显著相关的因素包括诊断时年龄小于50岁(p = 0.0065)、手术治疗(p < 0.001)、辅助化疗和放疗(分别为p < 0.001和p = 0.0072)、根治性手术治疗(p < 0.001)、疾病分期(p < 0.0001)、无黄疸(p = 0.0425)和无体重减轻(p = 0.0446)。在多变量分析中,显著变量为年龄、手术治疗、辅助化疗、根治性手术、疾病分期和无黄疸。

结论

胆管癌是已知预后较差的肿瘤。尽管如此,化疗是一个独立的生存因素,未来需要进一步研究以明确其在该疾病中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验